GVR Report cover Pharmaceutical Glass Packaging Market Size, Share & Trends Report

Pharmaceutical Glass Packaging Market Size, Share & Trends Analysis Report By Product (Vials, Bottles, Ampoules), By Drug Type (Generic, Branded, Biologic), By Region, And Segment Forecasts, 2022 - 2030

  • Report ID: GVR-2-68038-175-7
  • Number of Pages: 170
  • Format: Electronic (PDF)

Report Overview

The global pharmaceutical glass packaging market size was estimated at USD 17.0 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 9.2% from 2022 to 2030. Extensive utilization of generic injectable drugs coupled with high demand from the pharmaceutical industry is anticipated to drive market growth.

U.S. Pharmaceutical Glass Packaging Market Size, By Product, 2020 - 2030 (USD Billion)

Glass poses as a hindrance to atmospheric gases such as carbon dioxide and oxygen from entering the primary container, mitigating the risk of contamination of the drugs. Glass packaging lowers the drug’s susceptibility to degradation, such as hydrolysis and oxidation. Moreover, glass packaging helps in the resisting escape of volatile ingredients, thereby increasing drug stability. All these factors are anticipated to surge product demand in near future.

Growth in the global pharmaceutical market slowed considerably in 2017 due to the slow growth of the industry in emerging markets owing to low to moderate demand for pharmaceutical products. This was seen particularly in the case of the U.S., which is the world’s largest and most important pharmaceutical market. The sales of injection drugs were majorly affected within the market. However, the growing importance of generic drugs and access to better healthcare services in the economy is anticipated to provide opportunities for the market.

 The growing significance of cost-sensitivity and biotech drugs in the healthcare sector has resulted in the establishment of strict regulations related to drug delivery products. Multiple manufacturers working in the pharmaceutical glass manufacturing market are focused on packaging, aimed at increasing the shelf life of a product, and are therefore investing in vials.

The pharmaceutical glass packaging developers have been enhancing their product capabilities in order to cater to the changing pharmaceutical industry, which is anticipated to incline more toward biological drugs. Gerresheimer AG, for instance, has developed a metal-free 1 ml Gx RTF long Luer Lock syringe. This syringe uses a new technology in which the pin used to shape the cone is made of a special ceramic material instead of conventional tungsten or alternative metal.

The additional impact of COVID-19 pandemic has left the pharmaceutical industry at a steady growth yet high demand for medicines and other healthcare facilities. The surge in demand for pharmaceutical drugs, as a result of the pandemic, has affected the market positively. The demand is expected to reach new peaks in the case of approval for COVID-19 vaccines, developed by different institutions and companies in various countries.

For instance, the U.S. produces millions of surplus doses of vaccines that are packaged in large, multi-dose vials. These vials are either used domestically or distributed to other countries of the world. The U.S. surpassed 500 million doses of the Johnson & Johnson, Moderna, and Pfizer-BioNTech vaccines by 2021. Despite demand from state officials in the U.S., there have been various challenges for manufacturers in switching from large multi-dose vials to single-dose vials for supplying vaccines.

Presently, most vaccines in the U.S. are distributed in the form of single-dose vials or prefilled syringes, but the COVID-19 vaccines are being distributed through multi-dose vials owing to the requirement of their quick manufacturing in the early months of the inoculation campaign carried out in the country.

Product Insights

Bottles were the largest market segment, accounting for 34.7% share in 2021 in terms of global revenue. The pharmaceutical glass packaging market has been segmented based on the product as ampoules, bottles, vials, syringes, and cartridges. Vials have high analytical performance and great sustainability, which is expected to drive the segment with the second-fastest growth rate after ampoules. Therefore, the vials segment is expected to witness a rise in market share during the forecast period from 33.2% in 2021.

Vials are made from Type 1 borosilicate glass which imparts the desired chemical resistance properties to the glass vials. Ampoules are expected to witness the fastest growth, whereas the largest market share is anticipated to be held by bottles. It also accounted for a volume share of 74.8% in 2021 owing to its better analytical performance and suitability.

In July 2021, Stevanato Group, an Italian medical packaging firm went public with the listing of its IPO on the New York Stock Exchange. It has raised USD 672.0 million for the company which was founded in 1949 and has become a multinational packaging company. It is now manufacturing cartridges for insulin pens and provides vials and syringes for Covid-19 vaccines.

Glass bottles used for pharmaceutical packaging are categorized into two types depending on their size, namely, small bottles and large bottles. The large-size glass bottles are used for the packaging of reagents as well as transfusion and infusion bottles. The small glass bottles are used for the packaging of syrup bottles and other oral liquids. The small-sized bottles segment is expected to witness growth on account of numerous new opportunities including the rising consumption of oral tablets that are packaged in small bottles.

Ampoules that are largely developed from the glass are anticipated to grow with the most attractive CAGR, in terms of revenue, during the forecast period from 2022 to 2030 owing to the ability of glass to filter specific wavelengths, high microbiological control, and greater chemical resistance. Large numbers of ampoules are produced in compliance with the DIN ISO EN 9187-1/2 standard in sealed designs, funnel-type, and straight-stem.

Drug Type Insights

Generic drug type led the market and accounted for more than 72.2% share of the global revenue in 2021. The global market for generic drugs has seen a rise during the past several years due to increasing cases of chronic diseases, an aging population, and a rise in expiration of drug patents.

Furthermore, the efforts from governments and healthcare service providers to reduce healthcare expenditure & drug prices and provision of health insurance coverage are factors anticipated to fuel the consumption of generic drugs. The increased consumption of generics is expected to ascend demand for pharmaceutical glass packaging owing to its regulatory ease and extraordinary barrier property.

Global Pharmaceutical Glass Packaging Market Share, By Drug Type, 2021 (%)

Growth of the biologic drugs is majorly due to their ability to treat major chronic diseases, especially certain forms of autoimmune diseases and cancer. However, glass delaminating and chipping those results from surface degradation are anticipated to lower the growth of primary glass packaging for biologic drugs.

The generic drug segment in North America is expected to witness higher growth than branded segment, both in terms of volume and revenue, as it is affordable, whereas the patent expirations are going to further lead the branded segment to have a moderate growth rate. The primary glass packaging is expected to show sluggish growth on account of decreased volume sales of branded drugs.

The pharmaceutical industry is expected to largely benefit from biologics as they cater to the therapeutic aspects that are underserved. The biosimilar competition for the biologics has remained low resulting in moderate growth of the segment, thereby slowing the expansion of the segment in the market.

The U.S. boasts the presence of pharmaceutical giants and therefore is expected to remain a core region for the various business activities related to pharmaceutical glass packaging. Customer consolidation and increased competitive intensity in the country are expected to result in a significant increase in the volume of generic drug sales causing rapid change in market dynamics. This change coupled with patent expirations of numerous drugs is expected to constrain branded product sales in the U.S.

Regional Insights

North America dominated the market and accounted for more than 36.1% share of global revenue in 2021. The developing markets are expected to witness a surge in spending in the pharmaceutical industry in the upcoming years.

The U.S. is expected to remain a key driver and most important market for the growth of the pharmaceutical sector within the region with innovative products leading the growth. This growth is expected to be aided by the rise in generics in the region that are anticipated to witness consistently high demand in terms of volume and sales.

Pharmaceutical Glass Packaging Market  Trends by Region

Emerging markets are expected to show higher growth rates as compared to developed markets due to the rapid increase in consumer base and spending. Increased cases of chronic ailments, augmented healthcare awareness, and rising income levels are the factors expected to further aid the growth of emerging markets in Asia Pacific.

The governments in Asia Pacific are expanding their private and public healthcare coverage due to increased awareness.  Efforts of the government in developing regions to promote low-cost generic drugs and reduce healthcare costs are expected to result in an increased volume of pharmaceutical products further fueling the growth of the market within the region.

Europe region accounted for more than 17.8% of the volume share in 2021. The research-based pharmaceutical industry is a key asset of the European economy. The pharmaceutical glass packaging industry is on the rise owing to the growth in medical progress by means of research, development, and introduction of new medicines aimed at improving the health and quality of life of the patients in the region.

The national regulation that holds down prices & profits and results in market fragmentation is anticipated to be a major factor that differentiates the strengths of the European research-based industry and its American counterparts in the pharmaceutical sector.

Asia Pacific is anticipated to be the fastest-growing region in terms of revenue. This growth in demand can be ascertained by the presence of numerous small and medium scaled production units in the region. The region also enjoys a lenient regulatory regime that works out to support the manufacturers, along with attracting foreign investment. Usually, companies like Corning and Schott AG partner with small scaled production units in the region which provides them a platform to expand their regional presence along with gaining higher market share.

Key Companies & Market Share Insights

Numerous pharmaceutical glass manufacturing companies are primarily concentrated in developed regions such as Europe and North America resulting in well-established supply chain and production systems in these regions. However, manufacturers are shifting their base to countries such as Brazil, India, and China due to low labor costs and the growth of the opportunities offered by these countries. The generic sector, in particular, is expected to drive the demand for pharmaceutical glass packaging in these countries during the forecast period.

For instance, in February 2022, a subsidiary of India-based medicine maker Emcure Pharmaceuticals, namely Gennova Biopharmaceuticals started manufacturing of Covid-19 vaccine which will target the Omicron variant on its mRNA technology platform. The company plans to reach the Drug Controller General of India (DCGI) office for the clinical trials of the booster shot of the mRNA vaccine.

Emerging players including SGD S.A and Şişecam Group are considered rising players in the global market. This is due to the continuous investments in the expansion of the business and production of glass pharma packaging. For instance, SGD S.A has been upgrading its plants in China and Spain with advanced equipment in order to boost production. In August 2018, the company invested approximately USD 7.8 million to rebuild the furnace and boosted production by 11%. Some of the prominent players in the global pharmaceutical glass packaging market include:

  • Corning Incorporated

  • Nipro Corporation

  • SGD S.A.

  • Stölzle-Oberglas GmbH

  • Bormioli Pharma S.r.l

  • West Pharmaceutical Services, Inc.

  • Schott AG

  • Gerresheimer AG

  • Shandong Medicinal Glass Co., Ltd.

  • Beat son Clark

  • Ardagh Group S.A

  • Arab Pharmaceutical Glass Co.

  • Piramal Enterprises Ltd.

  • Şişecam Group

  • Owens-Illinois, Inc.

Pharmaceutical Glass Packaging Market Report Scope 

Report Attribute


Market size value in 2022

USD 18.2 billion

Revenue forecast in 2030

USD 37.6 billion

Growth Rate

CAGR of 9.2% from 2022 to 2030

Base year for estimation


Historical data

2017 - 2020

Forecast period

2022 - 2030

Quantitative units

Revenue in USD million; Volume in million units; CAGR from 2022 to 2030

Report coverage

Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors,  trends

Segments covered

Product, drug type,  region

Regional scope

North America; Europe;, Asia Pacific; South America;  Middle East & Africa

Country scope

U.S.; Canada; Mexico; UK; Germany; France; Italy; Spain; China; Japan; India; South Korea; Australia; Brazil; Saudi Arabia

Key companies profiled

Corning Incorporated; Nipro Corporation; SGD S.A; Stölzle-Oberglas GmbH; Bormioli Pharma S.r.l; West Pharmaceutical Services, Inc.; Schott AG; Gerresheimer AG; Shandong Medicinal Glass Co., Ltd.; Beat son Clark; Ardagh Group S.A; Arab Pharmaceutical Glass Co.; Piramal Enterprises Ltd.; Şişecam Group; Owens-Illinois, Inc.

Customization scope

Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options


Global Pharmaceutical Glass Packaging Market Segmentation

This report forecasts revenue growth at the global, regional, and country levels along with provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2017 to 2030. For this study, Grand View Research has segmented the global pharmaceutical glass packaging market report based on the product, drug type and region:

Global Pharmaceutical Glass Packaging Market  Segmentation

  • Product Outlook (Volume, Million Units; Revenue, USD Million; 2017 - 2030)

    • Vials

      • Small vials

      • Large vials

    • Bottles

      • Small bottles

      • Large bottles

    • Cartridges & Syringes

    • Ampoules

  • Drug Type Outlook (Volume, Million Units; Revenue, USD Million; 2017 - 2030)

    • Generic

    • Branded

    • Biologic

  • Regional Outlook (Volume, Million Units; Revenue, USD Million; 2017 - 2030)

    • North America

      • U.S.

      • Canada

      • Mexico

    • Europe

      • UK

      • Germany

      • France

      • Italy

      • Spain

    • Asia Pacific

      • China

      • Japan

      • India

      • South Korea

      • Australia

    • Central & South America (CSA)

      • Brazil

    • Middle East & Africa (MEA)

      • Saudi Arabia

Frequently Asked Questions About This Report

gvr icn


gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon